Fellowship · Baltimore, MD
Sponsored by Johns Hopkins University School of Medicine
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Neuro-oncology · 2021 · 9,364 citations · Daniel Brat
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
The New England journal of medicine · 2022 · 755 citations · Jonathan Glass
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas.
Neuro-oncology · 2025 · 110 citations · Daniel Brat
Glioma progression is shaped by genetic evolution and microenvironment interactions.
Cell · 2022 · 385 citations · Daniel Brat
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Nature genetics · 2021 · 434 citations · Jonathan Glass
Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
Science translational medicine · 2024 · 158 citations · Jonathan Glass
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture.
Nature genetics · 2021 · 361 citations · Juan Troncoso
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
Nature medicine · 2024 · 142 citations · Juan Troncoso